TTTakeshi Tsugawa

Takeshi Tsugawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takeshi Tsugawa has a total of 198 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroyuki Tsutsumi

    Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan

    9 shared publications
  • Hirokazu Kimura

    Department of Clinical Engineering, Faculty of Medical Science and Technology, Gunma Paz University, Takasaki 370-0006, Japan

    7 shared publications
  • Yukihiko Kawasaki

    Department of Pediatrics Sapporo Medical University School of Medicine Sapporo Japan

    7 shared publications
  • Akihide Ryo

    Department of Bioinformatics and Integrative Omics, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan

    6 shared publications
  • Kenji Kondo

    Department of Pediatrics, Sunagawa City Hospital, Sunagawa, Japan

    6 shared publications
  • Mitsuru Sada

    Department of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka 181-8611, Tokyo, Japan

    6 shared publications

Latest Publications

  • Long‐term trends in pediatric intussusception in Hokkaido, Japan, 2007–2024 across the rotavirus vaccination era

    by Yuya Fukuda, Yoshinori Araki, Toshitaka Kizawa, Kenji Kondo, Wataru Ikemoto, Kouhei Nishino, Toshiya Sato, Masayoshi Kikuchi, Kazushige Nagai, Minako Kihara, et al.

    Objectives: Pediatric intussusception is the most common cause of acute intestinal obstruction in young children. We investigated long‐term epidemiological trends in pediatric intussusception before and after rotavirus vaccine introduction and during the COVID‐19 pandemic in Hokkaido, Japan. Methods: A retrospective multicenter surveillance study was conducted at 17 hospitals in Hokkaido between 2007 and 2024. Clinical characteristics, management, outcomes, and viral antigen test results were collected. Only cases fulfilling Brighton Level 1 diagnostic certainty were included. Annual incidence rates were calculated using regional population statistics. Results: A total of 513 children met the inclusion criteria, with 93.0% aged 0–4 years. Non‐surgical reduction was successful in 94.0% of cases, and no deaths or long‐term sequelae were observed. Among infants aged <1 year, incidence decreased from 99.4 per 100,000 person‐years during the pre‐vaccination period (2007–2011) to 69.9 during the voluntary vaccination period (2012–2019), and was 79.7 during the universal vaccination/COVID‐19 period (2020–2024). Corresponding incidence rates among children aged 0–4 years were 55.4, 36.7, and 38.1 per 100,000 person‐years, respectively. Conclusion: Among children aged 0–4 years, intussusception incidence was lower during the period following rotavirus vaccine introduction than during the pre‐vaccine period and remained broadly stable during the universal vaccination and COVID‐19 period. The observed changes cannot be attributed to rotavirus vaccination alone because of concurrent changes in infectious disease circulation and other population‐level factors. Continued surveillance is warranted to further clarify the epidemiology of pediatric intussusception.

  • Open Access

    Whole‐Genome Characterization of Rare Artiodactyl‐Like G10P [14] and G8P [14] Rotavirus A Strains Detected in Pediatric Gastroenteritis Cases in Hokkaido Prefecture, Japan

    by Akira Takebayashi, Yuya Fukuda, Yoshiki Fujii, Hiroshi Nihira, Minako Kihara, Yoshimasa Kudou, Shuhei Adachi, Noritaka Shintani, Takeshi Tsugawa

    Rotavirus alphagastroenteritidis (RVA) is the leading cause of acute gastroenteritis in young children worldwide, as well as in a wide range of animal species. In 2020 and 2022, we identified three unusual RVA strains in pediatric gastroenteritis patients in Hokkaido Prefecture, Japan, using next‐generation sequencing: one G10P[14] strain (Ni20‐23) and two G8P[14] strains (Ni20‐37 and To22‐1). All three strains possessed the genotype constellation G10/G8‐P[14]‐I2‐R2‐C2‐M2‐A3‐N2‐T6‐E2‐H3. Phylogenetic analyses of these 11 genome segments indicated that the strains were artiodactyl‐like RVAs. However, no genome segment exhibited > 98% nucleotide identity among the three strains, suggesting that they originated from distinct artiodactyl RVA strains. Furthermore, no previously reported artiodactyl RVA strain showed > 90% nucleotide identity across all 11 segments; thus, the direct animal origins of these strains remain unclear. As observed in these strains, nearly all artiodactyl‐like RVAs previously detected in humans have carried the VP4 genotype P[14], indicating a potential role of P[14] in facilitating cross‐species transmission. One strain (To22‐1/G8P[14]) was detected in a child who had received two doses of Rotarix (G1P[8] monovalent vaccine). Comparative amino acid analysis of VP4 between the To22‐1/G8P[14] strain and the P[8] Rotarix vaccine strain revealed substitutions at 18 of 37 (48.6%) known antigenic epitope sites, suggesting a potential antigenic mismatch. Continued surveillance and further studies are warranted to elucidate the mechanisms underlying interspecies transmission of artiodactyl‐like P[14] RVAs and to assess the effectiveness of current vaccines against such strains.

  • Open Access

    Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy

    by Yusuke Iizuka, Masanori Sasaki, Kojiro Terada, Takuro Sakai, Yoshinobu Nagaoka, Shinobu Fukumura, Jeffery D. Kocsis, Takeshi Tsugawa, Osamu Honmou

    Background: Podocytes are essential for kidney function, and their dysfunction can result in nephrotic syndrome, such as minimal change disease (MCD). Oxidative stress contributes to podocyte damage. We investigated the therapeutic potential of intravenously infused mesenchymal stem cells (MSCs) in a puromycin aminonucleoside (PAN)-induced rodent MCD model, focusing on oxidative stress modulation. Methods: Sprague-Dawley rats were divided into three groups: intact, PAN-Vehicle, and PAN-MSC. MCD was induced through subcutaneous PAN injection. MSCs were infused intravenously in the PAN-MSC group on day 7. Urinary albumin, serum albumin, and creatinine levels were assessed. Histological analysis of the renal cortex was performed. Podocyte protein (NPHS1, NPHS2, and PODXL) and antioxidant enzyme (SOD1, SOD2, and GPX1) levels were measured using quantitative real-time reverse-transcription PCR (qRT-PCR). Results: MSC infusion significantly reduced proteinuria and restored podocyte structure in the PAN-MSC group. Electron microscopy revealed that infused MSCs could inhibit the fusion of the foot process induced by PAN injection. qRT-PCR showed that intravenous infusion of MSCs rescued the inhibition of GPX1 expression. GFP-labeled MSCs accumulated at the podocyte injury sites. Conclusion: Systemic MSC infusion mitigates PAN-induced MCD by reducing proteinuria, preserving podocyte structure, and modulating oxidative stress via the GPX1 pathway, offering a potential therapeutic approach for nephrotic syndrome.


  • Open Access

    Molecular Evolutionary Analyses of the RNA-Dependent RNA Polymerase (RdRp) Region and VP1 Gene in Sapovirus GI.1 and GI.2

    by Fuminori Mizukoshi, Ryusuke Kimura, Tatsuya Shirai, Asumi Hirata-Saito, Eri Hiraishi, Kosuke Murakami, Yen Hai Doan, Hiroyuki Tsukagoshi, Nobuhiro Saruki, Takeshi Tsugawa, et al.

    Human sapovirus (HuSaV) is a significant cause of gastroenteritis. This study aims to analyze the evolutionary dynamics of the RNA-dependent RNA polymerase (RdRp) and capsid (VP1) genes of the HuSaV GI.1 and GI.2 genotypes between 1976 and 2020. Using bioinformatics tools such as the Bayesian phylogenetics software BEAST 2 package (v.2.7.6), we constructed time-scale evolutionary trees based on the gene sequences. Most of the recent common ancestors (MRCAs) of the RdRp region and VP1 gene in the present HuSaV GI.1 diverged around 1930 and 1933, respectively. The trees of the HuSaV GI.1 RdRp region and VP1 gene were divided into two clusters. Further, the MRCAs of the RdRp region and VP1 gene in HuSaV GI.2 diverged in 1960 and 1943, respectively. The evolutionary rates were higher for VP1 gene in HuSaV GI.1 than that in HuSaV GI.2, furthermore, were higher in GI.1 Cluster B than GI.1 Cluster A. In addition, a steep increase was observed in the time-scaled genome population size of the HuSaV GI.1 Cluster B. These results indicate that the HuSaV GI.1 Cluster B may be evolving more actively than other genotypes. The conformational B-cell epitopes were predicted with a higher probability in RdRp for GI.1 and in VP1 for GI.2, respectively. These results suggest that the RdRp region and VP1 gene in HuSaV GI.1 and GI.2 evolved uniquely. These findings suggest unique evolutionary patterns in the RdRp region and VP1 gene of HuSaV GI.1 and GI.2, emphasizing the need for a ‘One Health’ approach to better understand and combat this pathogen.


  • Successful treatment of pediatric mature B‐cell lymphoma with MYC and BCL6 rearrangements

    by Ryo Hamada, Masaki Yamamoto, Yusuke Akane, Keita Igarashi, Takeshi Tsugawa

  • Open Access

    Children’s cognition and attitudes during long-term cancer treatment: an ethnographic study

    by Ryoko Michinobu, Masaki Yamamoto, Keita Igarashi, Yoshiyuki Sakai, Yusuke Akane, Dai Yamamoto, Akira Takebayashi, Takahiro Mikami, Hiroyuki Tsutsumi, Takeshi Tsugawa

    Background Cancer treatment for children is typically long-term and difficult, and the experience is unique for each child. When designing child-centred care, individuals’ values and preferences are considered equally important as the clinical evidence; therefore, understanding children’s thoughts and attitudes while they receive long-term treatment could offer valuable insights for better clinical practice. Methods We conducted long-term consecutive participatory observations and interviews with seven children, who were hospitalised and receiving cancer treatment for the first time. The daily observational data on those children’s discourses, behaviours and interactions with health professionals were systematically collected and thematically examined. The analysis was expanded to explore significant narratives for each child to capture their narrative sequence over time. Results The initial analysis identified 685 narrative indexes for all observation data, which were categorised into 21 sub-codes. Those sub-codes were assembled into five main themes by thematic analysis: making promises with health professionals, learning about the treatment procedures through participation, taking care of oneself, increasing the range of activities one can perform and living an ordinary life. Conclusion We observed a forward-looking attitude toward understanding cancer, accepting treatment and looking forward to the future among children undergoing in-hospital cancer treatment. In addition, the children developed cognitively, affectively and relationally throughout cancer treatment processes. These findings have implications for better clinical practice in child-centred care, including children’s participation in shared decision-making in paediatric oncology.


  • Changing Patterns of Infectious Diseases Among Hospitalized Children in Hokkaido, Japan, in the Post-COVID-19 Era, July 2019 to June 2022

    by Yuya Fukuda, Atsuo Togashi, Satoshi Hirakawa, Masaki Yamamoto, Shinobu Fukumura, Tomohiro Nawa, Saho Honjo, Jun Kunizaki, Kouhei Nishino, Toju Tanaka, et al.

    Background: Many reports have reported a reduction in respiratory infectious diseases and infectious gastroenteritis immediately after the coronavirus disease 2019 (COVID-19) pandemic, but data continuing into 2022 are very limited. We sought to understand the current situation of various infectious diseases among children in Japan as of July 2022 to improve public health in the post-COVID-19 era. Methods: We collected data on children hospitalized with infectious diseases in 18 hospitals in Japan from July 2019 to June 2022. Results: In total, 3417 patients were hospitalized during the study period. Respiratory syncytial virus decreased drastically after COVID-19 spread in early 2020, and few patients were hospitalized for it from April 2020 to March 2021. However, an unexpected out-of-season re-emergence of respiratory syncytial virus was observed in August 2021 (50 patients per week), particularly prominent among older children 3–6 years old. A large epidemic of delayed norovirus gastroenteritis was observed in April 2021, suggesting that the nonpharmaceutical interventions for COVID-19 are less effective against norovirus. However, influenza, human metapneumovirus, Mycoplasma pneumoniae, and rotavirus gastroenteritis were rarely seen for more than 2 years. Conclusions: The incidence patterns of various infectious diseases in Japan have changed markedly since the beginning of the COVID-19 pandemic to the present. The epidemic pattern in the post-COVID-19 era is unpredictable and will require continued careful surveillance.


  • Characteristics of intussusception among children in Hokkaido, Japan, during the pre‐ and post‐rotavirus vaccine eras (2007–2016)

    by Yuya Fukuda, Yusuke Akane, Saho Honjo, Yukihiko Kawasaki, Hiroyuki Tsutsumi, Takeshi Tsugawa

    Aim: To analyse the epidemiology of intussusception in Hokkaido Prefecture, Japan during a 10‐year period spanning the introduction of the rotavirus (RV) vaccine (2007–2016).Methods: Using a standard questionnaire, a retrospective surveillance was conducted across 17 hospitals with paediatric beds in Hokkaido Prefecture. We compared the data between the pre‐vaccine era (2007–2011) and post‐vaccine era (2012–2016).Results: In total, 208 and 110 intussusception cases were in the pre‐ and post‐vaccine eras, respectively. A significant reduction of the intussusception incidence in children aged p = 0.004). There was a relatively high‐positive RV antigen detection rate (29.4%, 5/17) during the RV epidemic period in Japan (March–May) in the pre‐vaccine era. None of the intussusception cases in the 31 patients with a history of RV vaccination occurred within 1 month after the administration of an RV vaccine dose.Conclusions: The incidence of intussusception in children aged <1 year decreased significantly after RV vaccine introduction in Japan. Another survey is needed to determine how the incidence of intussusception has changed further since the introduction of routine RV vaccination in 2020.


  • Sequence analysis of a feline- and porcine-origin G3P[9] rotavirus A strain in a child with acute gastroenteritis in Japan

    by Yuya Fukuda, Kaoru Araki, Megumi Hara, Yuji Yamashita, Shuhei Adachi, Saho Honjo, Atsuo Togashi, Satoshi Hirakawa, Shinobu Fukumura, Masaki Yamamoto, et al.

    We isolated the rare G3P[9] rotavirus strain RVA/Human-wt/JPN/R11-035/2015/G3P[9] from a 2-year-old girl presenting with vomiting and diarrhea who had daily contact with cats in Japan, 2015. Full-genome analysis revealed that the R11-035 strain had an AU-1-like genetic constellation, except for the NSP3 (T) gene: G3-P[9]-I3-R3-C3-M3-A3-N3-T1-E3-H6. Phylogenetic analysis showed that strain R11-035 is closely related to human/feline-like human strains, and only the NSP3 (T1) gene was clustered together with Taiwanese porcine strains. We postulate that the R11-035 strain was directly transmitted from a cat to the patient and acquired its NSP3 gene through intergenotype reassortment with porcine strains before being transmitted to humans.